Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -5.39% is in line with its 5-year average of -5.31%, near the high end of its 5-year range (-255.88%–53.02%).
34.86% below its 12-month average of -4.00%.
Reported quarterly EBITDA margin; no daily interpolation. Q4 FY2026 (2026-05-31): -17.04%.
EBITDA MARGIN
-5.39%
EBITDA MARGIN AVG TTM
-4.00%
EBITDA MARGIN AVG 3Y
-6.70%
EBITDA MARGIN AVG 5Y
-5.31%
EBITDA MARGIN AVG 10Y
-0.66%
EBITDA MARGIN AVG 15Y
3.29%
EBITDA MARGIN AVG 20Y
5.78%
CURRENT VS TTM AVG
-34.86%
CURRENT VS 3Y AVG
+19.55%
CURRENT VS 5Y AVG
-1.58%
CURRENT VS 10Y AVG
-720.01%
CURRENT VS 15Y AVG
-263.71%
CURRENT VS 20Y AVG
-193.25%
AngioDynamics, Inc.
Market Cap
$645.20M
EBITDA Margin
-5.39%
TTM Avg
-4.00%
3Y Avg
-6.70%
5Y Avg
-5.31%
Market Cap
$637.59M
EBITDA Margin
-20.76%
TTM Avg
-19.02%
3Y Avg
-15.62%
5Y Avg
12.71%
Market Cap
$675.41M
EBITDA Margin
-178.29%
TTM Avg
-244867.52%
3Y Avg
-123424.79%
5Y Avg
-82415.31%
Market Cap
$600.84M
EBITDA Margin
40.74%
TTM Avg
33.91%
3Y Avg
-21.02%
5Y Avg
1.67%
Market Cap
$589.38M
EBITDA Margin
-970.11%
TTM Avg
-861.99%
3Y Avg
-583.02%
5Y Avg
-735.09%
Market Cap
$587.93M
EBITDA Margin
-3.28%
TTM Avg
-4.19%
3Y Avg
-6.19%
5Y Avg
-9.77%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AngioDynamics, Inc. (ANGO) | $645.20M | -5.39% | -4.00% | -6.70% | -5.31% |
| Aura Biosciences, Inc. (AURA)vs › | $647.51M | N/A | N/A | N/A | N/A |
| Fulgent Genetics, Inc. (FLGT)vs › | $637.59M | -20.76% | -19.02% | -15.62% | 12.71% |
| Climb Bio, Inc. (CLYM)vs › | $636.76M | N/A | N/A | N/A | N/A |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $675.41M | -178.29% | -244867.52% | -123424.79% | -82415.31% |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $600.84M | 40.74% | 33.91% | -21.02% | 1.67% |
| Annexon, Inc. (ANNX)vs › | $689.78M | N/A | N/A | N/A | N/A |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $589.38M | -970.11% | -861.99% | -583.02% | -735.09% |
| OrthoPediatrics Corp. (KIDS)vs › | $587.93M | -3.28% | -4.19% | -6.19% | -9.77% |
| Faeth Therapeutics, Inc. (FTH)vs › | $698.60M | N/A | N/A | N/A | N/A |
Gross Margin
54.6%
EBITDA Margin
-5.4%
Operating Margin
-12.5%
Net Margin
-11.5%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-05-31 | -17.04% |
| 2026-02-28 | -1.07% |
| 2025-11-30 | 4.19% |
| 2025-08-31 | -6.12% |
| 2025-05-31 | 0.06% |
| 2025-02-28 | -5.08% |
| 2024-11-30 | -5.81% |
| 2024-08-31 | -9.35% |
| 2024-05-31 | -10.75% |
| 2024-02-29 | -255.88% |
| 2023-11-30 | -8.14% |
| 2023-08-31 | 53.02% |
| 2023-05-31 | -14.58% |
| 2023-02-28 | -1.35% |
| 2022-11-30 | -0.35% |
| 2022-08-31 | -6.92% |
| 2022-05-31 | 1.46% |
| 2022-02-28 | 2.85% |
| 2021-11-30 | -1.79% |
| 2021-08-31 | -1.43% |
| 2021-05-31 | -19.60% |
| 2021-02-28 | 3.71% |
| 2020-11-30 | 2.20% |
| 2020-08-31 | 2.07% |
| 2020-05-31 | -257.76% |
| 2020-02-29 | 0.29% |
| 2019-11-30 | 3.54% |
| 2019-08-31 | 6.63% |
| 2019-05-31 | -10.14% |
| 2019-02-28 | 3.70% |
| 2018-11-30 | 4.55% |
| 2018-08-31 | -0.62% |
| 2018-05-31 | 11.55% |
| 2018-02-28 | 12.62% |
| 2017-11-30 | 8.08% |
| 2017-08-31 | 6.95% |
| 2017-05-31 | -5.73% |
| 2017-02-28 | 13.21% |
| 2016-11-30 | 24.40% |
| 2016-08-31 | 11.04% |
| 2016-05-31 | 2.85% |
| 2016-02-29 | 10.24% |
| 2015-11-30 | 8.70% |
| 2015-08-31 | 8.75% |
| 2015-05-31 | 9.96% |
| 2015-02-28 | -1.59% |
| 2014-11-30 | 12.89% |
| 2014-08-31 | 11.38% |
| 2014-05-31 | 9.74% |
| 2014-02-28 | 15.68% |
| 2013-11-30 | 10.69% |
| 2013-08-31 | 8.75% |
| 2013-05-31 | 8.76% |
| 2013-02-28 | 8.42% |
| 2012-11-30 | 13.12% |
| 2012-08-31 | 11.99% |
| 2012-05-31 | -5.64% |
| 2012-02-29 | 0.84% |
| 2011-11-30 | 12.16% |
| 2011-08-31 | 10.75% |
| 2011-05-31 | 2.40% |
| 2011-02-28 | 15.33% |
| 2010-11-30 | 15.65% |
| 2010-08-31 | 12.64% |
| 2010-05-31 | 16.02% |
| 2010-02-28 | 16.53% |
| 2009-11-30 | 15.95% |
| 2009-08-31 | 13.15% |
| 2009-05-31 | 15.04% |
| 2009-02-28 | 11.45% |
| 2008-11-30 | 16.03% |
| 2008-08-31 | 15.18% |
| 2008-05-31 | 6.05% |
| 2008-02-29 | 24.35% |
| 2007-11-30 | 16.69% |
| 2007-08-31 | 14.48% |
| 2007-05-31 | 14.45% |
| 2007-03-03 | -71.26% |
| 2006-12-02 | 13.90% |
| 2006-09-02 | 9.61% |
| 2006-05-31 | 14.54% |
| 2006-02-25 | 15.93% |
| 2005-11-26 | 14.26% |
| 2005-08-27 | 13.07% |
| 2005-05-31 | 15.72% |
| 2005-02-26 | 15.13% |
| 2004-11-27 | 13.78% |
| 2004-08-28 | 11.09% |
| 2004-05-31 | 14.65% |
| 2004-02-29 | 9.25% |
| 2003-05-31 | 9.33% |
| 2003-02-28 | 100.00% |
